CD19 and neoplasm: In this study, we characterize ENG T cells specific for CD19-positive malignancies (CD19-ENG T cells) and show that they are activated and kill tumor cells in an antigen dependent manner, are able to recruit bystander T cells to tumor cells, and have antitumor activity in preclinical models.